Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 4
2006 1
2008 2
2009 2
2011 1
2012 3
2013 4
2014 10
2015 5
2016 4
2017 5
2018 1
2019 5
2020 5
2021 13
2022 14
2023 8
2024 10
2025 14
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.
Piella EM, Chiarandon AM, Albanese M, Puddu EM, Pistoia F, Saporito G, Altieri M, Giuliani G, Vaghi G, Sances G, Munafò A, Chiarugi A, Ornello R, De Santis F, Valente M, Rao R, Russo A, Silvestro M, Roveta F, Montisano DA, Grazzi L, Battistini S, Boscain F, Mampreso E, Paolicelli D, Sacco S, Tassorelli C, Rubino E, Prudenzano MP, Rainero I; Italian Headache Registry (RICe) Study Group. Piella EM, et al. Among authors: albanese m. Neurol Sci. 2026 Apr 17;47(5):430. doi: 10.1007/s10072-026-09029-w. Neurol Sci. 2026. PMID: 41991825 No abstract available.
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.
Iannone LF, Sebastianelli G, Santis F, Corrado M, Marcosano M, Ornello R, Grazzi L, Montisano DA, Cesaris F, Munafò A, Vigani G, Avino G, Trimboli M, Albanese M, Russo A, Volta GD, Romozzi M, Calabresi P, Castro FL, Boccalini A, Merlo P, Prudenzano MP, Valente MR, Rainero I, Giuliani G, Altieri M, Fofi L, Doretti A, Vaghi G, Pistoia F, Lanni C, Ferrandi D, Rufa A, Battistini S, Coppola G, Geppetti P, Sacco S, Guerzoni S, Altamura C, Vernieri F; Italian Headache Registry (RICe) Study Group. Iannone LF, et al. Among authors: albanese m. Cephalalgia. 2026 Mar;46(3):3331024261416490. doi: 10.1177/03331024261416490. Epub 2026 Mar 25. Cephalalgia. 2026. PMID: 41878762
Human olfactory sensitivity varies across geographical locations.
Reichert A, Abraham NM, Abraham JN, Albanese ML, Alizadeh R, Aloulou I, Chen L, Enecilla MLB, Fornazieri MA, Frasnelli J, Fuselli JM, Gansatao F, Guducu C, Hernandez AK, Hofer MK, Husain S, Kamel R, Lamond E, Loy F, Mahmut MK, Marek D, Masala C, Michaluk É, Miri I, Mirsalehi M, Miteva P, Moura IB, Musa A, Naija H, Nakaachi K, Pinto JM, Mazal PP, Radwan A, Rafiei F, Rawat D, Resler K, Scussiatto HO, Sheta HA, Thodupunoori SM, Turner BJ, Van Oosterhout N, Wu H, Yoshino A, Zou L, Zyzelewicz B, Hummel T, Oleszkiewicz A. Reichert A, et al. Among authors: albanese ml. Sci Rep. 2026 Feb 18;16(1):9713. doi: 10.1038/s41598-026-38727-w. Sci Rep. 2026. PMID: 41708759 Free PMC article.
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).
Iannone LF, Piella EM, Montisano DA, Fasano C, Sebastianelli G, Coppola G, Ferrandi D, Lanni C, Prudenzano MP, de Tommaso M, Merlo P, De Cesaris F, Chiarugi A, Munafò A, Pistoia F, Ornello R, Doretti A, Grazzi L, Lo Castro F, De Icco R, Vaghi G, Avino G, Romozzi M, Calabresi P, Battistini S, Rufa A, Albanese M, Trimboli M, Carlucci G, Silvestro M, Russo A, Rainero I, Valente MR, Fofi L, Marcosano M, Geppetti P, Altamura C, Vernieri F, Tassorelli C, Sacco S, Guerzoni S; Italian Headache Registry (RICe) Study Group. Iannone LF, et al. Among authors: albanese m. Cephalalgia. 2026 Feb;46(2):3331024251414659. doi: 10.1177/03331024251414659. Epub 2026 Feb 12. Cephalalgia. 2026. PMID: 41684106 Free article.
Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study.
Barbanti P, Egeo G, Doretti A, Pistoia F, Rinalduzzi S, Strumia S, Aurilia C, Scatena P, Autunno M, Salerno A, Galli A, Altavilla R, Messina S, Zanferrari C, Bruno P, Camarda C, D'Onofrio F, Iovene V, Ranieri A, Bono F, de Souza JS, Carnevale A, Di Clemente L, Zucco M, Bandettini Di Poggio ML, Vinciguerra L, Borrello L, Fiorentini G, Vecchio R, Drago V, Torelli P, Albanese M, Tomino C, Bonassi S, Porreca A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. Among authors: albanese m. J Headache Pain. 2026 Jan 31;27(1):68. doi: 10.1186/s10194-026-02277-3. J Headache Pain. 2026. PMID: 41620660 Free PMC article.
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
Caronna E, Mas-de-Les-Valls R, Egeo G, Millán Vázquez M, Nieves-Castellanos C, Portocarrero-Sánchez L, Vaghi G, Rodríguez-Montolio J; as the European Real-World Study on the Use of Anti-CGRP Monoclonal Antibodies in Migraine (EUREkA) Study Group; Jaimes A, Muñoz-Vendrell A, Oliveira R, Polanco M, González Osorio Y, Canales J, Ornello R, Thunstedt C, Fernández-Lázaro I, Husøy A, Sánchez-Soblechero A, Nunes Vicente B, Riesco N, Flores Pina B, Fernandes C, Lopez AA, Martins-Silva E, Budrewicz S, Gallardo VJ, Gómez Dabó L, Torres-Ferrus M, Alpuente A, Torelli P, Aurilia C, Lamas R, Ruiz Castrillo MJ, De Icco R, Sances G, Broadhurst S, Winstanley J, Gómez A, Campoy S, Marques I, Parreira E, Gárate G, Pascual J, Guerrero Peral AL, Caponnetto V, Straube A, Gonzalez-Martinez A, Quintas S, Sánchez-Del-Río M, Tronvik E, Venegas Pérez B, Oterino Duran A, Rodrigues M, Cevoli S, Colombo B, Trimboli M, Frediani F, d'Onofrio F, Aguggia M, Salerno A, Carnevale A, Zucco M, Albanese M, Finocchi C, Ranieri A, Zoroddu F, Autunno M, Sanahuja J, Waliszewska-Prosół M, Pereira L, Layos-Romero A, Luzeiro I, Dorado L, Alvarez-Escudero R, Martins IP, Sundal C, Irimia P, Lozano Ros A, Gago-Veiga AB, J… See abstract for full author list ➔ Caronna E, et al. Among authors: albanese m. Neurology. 2026 Feb 24;106(4):e214659. doi: 10.1212/WNL.0000000000214659. Epub 2026 Jan 28. Neurology. 2026. PMID: 41604607
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study).
Vaghi G, Iannone LF, Corrado M, De Santis F, Romozzi M, Sebastianelli G, Dalla Volta G, Bolchini M, Burgalassi A, De Cesaris F, Albanese M, Mercuri Biagio N, Ornello R, Sacco S, Pistoia F, Saporito G, Casillo F, Avino G, Granato A, Russo A, Silvestro M, Vollono C, Trimboli M, Doretti A, Valente M, Cevoli S, Mampreso E, Tassorelli C, De Icco R. Vaghi G, et al. Among authors: albanese m. Ther Adv Neurol Disord. 2025 Dec 21;18:17562864251381886. doi: 10.1177/17562864251381886. eCollection 2025. Ther Adv Neurol Disord. 2025. PMID: 41446321 Free PMC article.
109 results